“…The use of RT in the treatment of numerous benign conditions, such as degenerative or dermatologic disorders [1,14,29,35] is still controversial, an international survey revealed a universal acceptance of prophylactic RT for prevention of HO [21]. Since the introductory report by Coventry & Scanlon in 1981 [8], numerous studies have been conducted to analyze the value of different dose-fractionation schedules for postoperative RT [3,8,11,18,20,26,28,31,32].…”